Published in J Am Soc Nephrol on December 08, 2011
Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients. BMC Nephrol (2012) 0.86
The crossroad of RAAS modulation, inflammation, and oxidative stress in dialysis patients: light at the end of the tunnel? J Am Soc Nephrol (2012) 0.80
Correlation of Inflammation and Lipoprotein (a) with Hypercoagulability in Hemodialysis Patients. Med Arch (2015) 0.79
Angiotensin converting enzyme inhibition increases ADMA concentration in patients on maintenance hemodialysis - a randomized cross-over study. BMC Nephrol (2015) 0.76
Add-on Protective Effect of Pentoxifylline in Advanced Chronic Kidney Disease Treated with Renin-Angiotensin-Aldosterone System Blockade - A Nationwide Database Analysis. Sci Rep (2015) 0.75
Immunologic Effects of the Renin-Angiotensin System. J Am Soc Nephrol (2017) 0.75
Gene silencing of endothelial von Willebrand Factor attenuates angiotensin II-induced endothelin-1 expression in porcine aortic endothelial cells. Sci Rep (2016) 0.75
Protocol of randomized control trial for effectiveness of angiotensin receptor blockers on blood pressure control among euvolemic hypertensive hemodialysis patients. Medicine (Baltimore) (2017) 0.75
Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med (2000) 29.25
Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis (1998) 10.70
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet (2003) 8.12
A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci U S A (1990) 5.31
The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int (2002) 4.29
Soluble CD40 ligand in acute coronary syndromes. N Engl J Med (2003) 4.06
Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med (1998) 3.59
Effect of bradykinin-receptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjects. N Engl J Med (1998) 3.18
Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. Nephrol Dial Transplant (2003) 2.10
Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. Nephrol Dial Transplant (2002) 2.05
Effects of amlodipine and valsartan on oxidative stress and plasma methylarginines in end-stage renal disease patients on hemodialysis. Kidney Int (2006) 1.94
Angiotensin II induces interleukin-6 in humans through a mineralocorticoid receptor-dependent mechanism. Hypertension (2006) 1.91
Effects of telmisartan added to Angiotensin-converting enzyme inhibitors on mortality and morbidity in hemodialysis patients with chronic heart failure a double-blind, placebo-controlled trial. J Am Coll Cardiol (2010) 1.90
Angiotensin induces inflammatory activation of human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (1999) 1.86
Immunologic function and survival in hemodialysis patients. Kidney Int (1998) 1.82
Endothelium and control of vascular function. State of the Art lecture. Hypertension (1989) 1.75
Combined angiotensin-converting enzyme inhibition and receptor blockade associate with increased risk of cardiovascular death in hemodialysis patients. Kidney Int (2011) 1.74
Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies. Kidney Int (2006) 1.74
Inflammatory signals associated with hemodialysis. Kidney Int (2002) 1.69
ACE inhibition with perindopril and endothelial function. Results of a substudy of the EUROPA study: PERTINENT. Cardiovasc Res (2006) 1.58
Effect of candesartan and various inflammatory markers on maintenance of sinus rhythm after electrical cardioversion for atrial fibrillation. Am J Cardiol (2007) 1.48
Oxidative stress and endothelial function in chronic renal failure. J Am Soc Nephrol (2001) 1.29
Bradykinin stimulates tumor necrosis factor and interleukin-1 release from macrophages. FEBS Lett (1989) 1.25
Overproduction of reactive oxygen species in end-stage renal disease patients: a potential component of hemodialysis-associated inflammation. Hemodial Int (2005) 1.22
Uremic toxicity, oxidative stress, and hemodialysis as renal replacement therapy. Semin Dial (2009) 1.21
Plasma F2-isoprostane levels are elevated in chronic hemodialysis patients. Clin Nephrol (2002) 1.20
Anti-inflammatory and metabolic effects of candesartan in hypertensive patients. Int J Cardiol (2005) 1.19
Oxidative stress in uremia. Curr Opin Nephrol Hypertens (2003) 1.18
Elevated plasma F2-isoprostanes in patients on long-term hemodialysis. Kidney Int (2001) 1.18
Role of the Rho GTPase in bradykinin-stimulated nuclear factor-kappaB activation and IL-1beta gene expression in cultured human epithelial cells. J Immunol (1998) 1.12
Impaired endothelium-dependent vasodilatation in renal failure in humans. Nephrol Dial Transplant (2001) 1.11
Circulating levels of plasminogen activator inhibitor type-1, tissue plasminogen activator, and thrombomodulin in hemodialysis patients: biochemical correlations and role as independent predictors of coronary artery stenosis. J Am Soc Nephrol (2001) 1.07
Bradykinin-induced dilation of human coronary arterioles requires NADPH oxidase-derived reactive oxygen species. Arterioscler Thromb Vasc Biol (2009) 1.04
Predictors of cardiovascular death in ESRD. Semin Nephrol (2005) 1.03
Bradykinin potentiates cytokine-induced prostaglandin biosynthesis in osteoblasts by enhanced expression of cyclooxygenase 2, resulting in increased RANKL expression. Arthritis Rheum (2007) 0.98
Soluble CD40 ligand and platelets: self-perpetuating pathogenic loop in thrombosis and inflammation? J Am Coll Cardiol (2004) 0.98
Plasminogen activator inhibitor 1 expression is regulated by the inflammatory mediators interleukin-1alpha, tumor necrosis factor-alpha, transforming growth factor-beta and oncostatin M in human cardiac myocytes. J Mol Cell Cardiol (2002) 0.98
Anti-inflammatory interleukin-10 genotype protects dialysis patients from cardiovascular events. Kidney Int (2002) 0.94
Role of the bradykinin B2 receptor for the local and systemic inflammatory response that follows severe reperfusion injury. Br J Pharmacol (2003) 0.92
Optimized assay for serum angiotensin-converting enzyme activity. Clin Chem (1981) 0.91
Association between interleukin-6 and carotid atherosclerosis in hemodialysis patients. Kidney Int (2002) 0.90
Angiotensin-converting enzyme inhibition and novel cardiovascular risk biomarkers: results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors (TRAIN) study. Am Heart J (2009) 0.89
Angiotensin, inflammation, hypertension, and cardiovascular disease. Curr Hypertens Rep (2001) 0.89
IL-1beta-induced transcriptional up-regulation of bradykinin B1 and B2 receptors in murine airways. Am J Respir Cell Mol Biol (2007) 0.89
Acute effects of hemodialysis on cytokine transcription profiles: evidence for C-reactive protein-dependency of mediator induction. Kidney Int (2006) 0.89
Different impact of biomarkers as mortality predictors among diabetic and nondiabetic patients undergoing hemodialysis. J Am Soc Nephrol (2003) 0.87
Effect of a kinin B2 receptor antagonist on LPS- and cytokine-induced neutrophil migration in rats. Br J Pharmacol (2003) 0.86
Smoking impairs bradykinin-stimulated t-PA release. Hypertension (2002) 0.86
Endogenous bradykinin contributes to increased plasminogen activator inhibitor 1 antigen following hemodialysis. J Am Soc Nephrol (2009) 0.84
Bradykinin and its metabolite bradykinin 1-5 inhibit thrombin-induced platelet aggregation in humans. J Pharmacol Exp Ther (2006) 0.83
Soluble CD40 ligand in acute and chronic heart failure. Eur Heart J (2005) 0.83
Elevated circulating levels of soluble CD-40 ligand in haemodialysis patients with symptomatic coronary heart disease. Nephrology (Carlton) (2008) 0.80
Bradykinin upregulates IL-8 production in human gingival fibroblasts stimulated by interleukin-1beta and tumor necrosis factor alpha. Regul Pept (2005) 0.80
Plasma hypercoagulability in haemodialysis patients: impact of dialysis and anticoagulation. Nephrol Dial Transplant (1997) 0.79
Activation of the kallikrein-kinin system in hemodialysis: role of membrane electronegativity, blood dilution, and pH. Kidney Int (1999) 0.79
Blood pressure reduction and tissue-type plasminogen activator release. Hypertension (2006) 0.78
Is there any relationship between serum levels of interleukin-10 and atherosclerosis in hemodialysis patients? Scand J Urol Nephrol (2005) 0.78
Increased blood flow induces oxidative stress through an endothelium- and nitric oxide-independent mechanism. Free Radic Biol Med (2010) 0.77
ACE inhibition with perindopril and biomarkers of atherosclerosis and thrombosis: results from the PERTINENT study. Atherosclerosis (2008) 0.76
Haemostatic complications in haemodialysis patients: effect of type of vascular access and dialysis filter. Scand J Clin Lab Invest (2003) 0.76
D-dimers in hemodialysis patients. Nephron (2001) 0.76
The diploid genome sequence of an Asian individual. Nature (2008) 46.29
A human gut microbial gene catalogue established by metagenomic sequencing. Nature (2010) 43.63
SOAP2: an improved ultrafast tool for short read alignment. Bioinformatics (2009) 39.47
SOAPdenovo2: an empirically improved memory-efficient short-read de novo assembler. Gigascience (2012) 20.89
The sequence and de novo assembly of the giant panda genome. Nature (2009) 15.76
Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. JAMA (2008) 7.50
Spectrum of acute renal failure in the intensive care unit: the PICARD experience. Kidney Int (2004) 6.04
Resequencing of 200 human exomes identifies an excess of low-frequency non-synonymous coding variants. Nat Genet (2010) 5.44
Single-cell exome sequencing and monoclonal evolution of a JAK2-negative myeloproliferative neoplasm. Cell (2012) 5.16
Resequencing 50 accessions of cultivated and wild rice yields markers for identifying agronomically important genes. Nat Biotechnol (2011) 4.84
Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int (2009) 4.72
The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies. J Am Coll Cardiol (2011) 4.57
The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int (2002) 4.29
The DNA methylome of human peripheral blood mononuclear cells. PLoS Biol (2010) 4.25
Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. Am J Kidney Dis (2003) 3.90
Effect of dipyridamole plus aspirin on hemodialysis graft patency. N Engl J Med (2009) 3.69
Estimating baseline kidney function in hospitalized patients with impaired kidney function. Clin J Am Soc Nephrol (2012) 2.94
Hemodialysis. N Engl J Med (2010) 2.89
Non-infected hemodialysis catheters are associated with increased inflammation compared to arteriovenous fistulas. Kidney Int (2009) 2.89
Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney Int (2004) 2.81
Urine neutrophil gelatinase-associated lipocalin moderately predicts acute kidney injury in critically ill adults. J Am Soc Nephrol (2009) 2.77
Complete resequencing of 40 genomes reveals domestication events and genes in silkworm (Bombyx). Science (2009) 2.68
Early intervention improves mortality and hospitalization rates in incident hemodialysis patients: RightStart program. Clin J Am Soc Nephrol (2007) 2.60
Timing of initiation of dialysis in critically ill patients with acute kidney injury. Clin J Am Soc Nephrol (2006) 2.56
Commonly used surrogates for baseline renal function affect the classification and prognosis of acute kidney injury. Kidney Int (2009) 2.53
Plasma cytokine levels predict mortality in patients with acute renal failure. Kidney Int (2004) 2.52
Fluid accumulation, recognition and staging of acute kidney injury in critically-ill patients. Crit Care (2010) 2.51
Routine intraoperative completion angiography after coronary artery bypass grafting and 1-stop hybrid revascularization results from a fully integrated hybrid catheterization laboratory/operating room. J Am Coll Cardiol (2009) 2.40
Biological markers of acute kidney injury. J Am Soc Nephrol (2011) 2.36
Functional variant of CYP4A11 20-hydroxyeicosatetraenoic acid synthase is associated with essential hypertension. Circulation (2004) 2.35
Association between physical performance and all-cause mortality in CKD. J Am Soc Nephrol (2013) 2.26
Historical variations in mutation rate in an epidemic pathogen, Yersinia pestis. Proc Natl Acad Sci U S A (2012) 2.22
Dysfunctional high-density lipoprotein in patients on chronic hemodialysis. J Am Coll Cardiol (2012) 2.21
Etomidate use and postoperative outcomes among cardiac surgery patients. Anesthesiology (2014) 2.13
Established and emerging plasma biomarkers in the prediction of first atherothrombotic events. Circulation (2004) 2.07
Low health literacy associates with increased mortality in ESRD. J Am Soc Nephrol (2010) 2.03
Sepsis as a cause and consequence of acute kidney injury: Program to Improve Care in Acute Renal Disease. Intensive Care Med (2010) 2.00
Ala92 type 2 deiodinase allele increases risk for the development of hypertension. Hypertension (2007) 1.98
An application of conditional logistic regression and multifactor dimensionality reduction for detecting gene-gene interactions on risk of myocardial infarction: the importance of model validation. BMC Bioinformatics (2004) 1.95
Interactive hemodynamic effects of dipeptidyl peptidase-IV inhibition and angiotensin-converting enzyme inhibition in humans. Hypertension (2010) 1.94
Dipeptidyl peptidase IV in angiotensin-converting enzyme inhibitor associated angioedema. Hypertension (2007) 1.93
Comparative effectiveness of incident oral antidiabetic drugs on kidney function. Kidney Int (2012) 1.92
Angiotensin II induces interleukin-6 in humans through a mineralocorticoid receptor-dependent mechanism. Hypertension (2006) 1.91
Association of dialysate bicarbonate concentration with mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis (2013) 1.90
SOAP3: ultra-fast GPU-based parallel alignment tool for short reads. Bioinformatics (2012) 1.89
G protein-coupled receptor kinase 4 gene variants in human essential hypertension. Proc Natl Acad Sci U S A (2002) 1.87
The kallikrein-kinin system: current and future pharmacological targets. J Pharmacol Sci (2005) 1.87
Associations among perceived and objective disease knowledge and satisfaction with physician communication in patients with chronic kidney disease. Kidney Int (2011) 1.87
Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1. Diabetes (2004) 1.85
Etiology of the protein-energy wasting syndrome in chronic kidney disease: a consensus statement from the International Society of Renal Nutrition and Metabolism (ISRNM). J Ren Nutr (2013) 1.85
Linkage of hypoalbuminemia, inflammation, and oxidative stress in patients receiving maintenance hemodialysis therapy. Am J Kidney Dis (2003) 1.83
Balancing Fistula First with Catheters Last. Am J Kidney Dis (2007) 1.83
Accelerated lean body mass loss in incident chronic dialysis patients with diabetes mellitus. Kidney Int (2005) 1.80
Ulcer formation with low-dose enteric-coated aspirin and the effect of COX-2 selective inhibition: a double-blind trial. Gastroenterology (2004) 1.79
Obesity and oxidative stress predict AKI after cardiac surgery. J Am Soc Nephrol (2012) 1.77
Combined angiotensin-converting enzyme inhibition and receptor blockade associate with increased risk of cardiovascular death in hemodialysis patients. Kidney Int (2011) 1.74
Plasminogen activator inhibitor-1 as a predictor of postoperative atrial fibrillation after cardiopulmonary bypass. Circulation (2007) 1.73
Beta-2 adrenergic receptor diplotype defines a subset of salt-sensitive hypertension. Hypertension (2006) 1.72
Inflammation and hypertension: the interplay of interleukin-6, dietary sodium, and the renin-angiotensin system in humans. Am J Hypertens (2011) 1.72
Comparative efficacy of yohimbine against pyridostigmine for the treatment of orthostatic hypotension in autonomic failure. Hypertension (2010) 1.69
Inflammatory signals associated with hemodialysis. Kidney Int (2002) 1.69
Improving medication use in newly admitted home healthcare patients: a randomized controlled trial. J Am Geriatr Soc (2002) 1.69
Influence of initiation of maintenance hemodialysis on biomarkers of inflammation and oxidative stress. Kidney Int (2004) 1.66
Genetic variants associated with angiotensin-converting enzyme inhibitor-associated angioedema. Pharmacogenet Genomics (2013) 1.65
Elevated urinary IL-18 levels at the time of ICU admission predict adverse clinical outcomes. Clin J Am Soc Nephrol (2010) 1.64
Development and results of a kidney disease knowledge survey given to patients with CKD. Am J Kidney Dis (2010) 1.64
The assessment, serial evaluation, and subsequent sequelae of acute kidney injury (ASSESS-AKI) study: design and methods. BMC Nephrol (2010) 1.63
Distinct injury markers for the early detection and prognosis of incident acute kidney injury in critically ill adults with preserved kidney function. Kidney Int (2013) 1.62
Aldosterone deficiency and mineralocorticoid receptor antagonism prevent angiotensin II-induced cardiac, renal, and vascular injury. Kidney Int (2012) 1.60
Spironolactone abolishes the relationship between aldosterone and plasminogen activator inhibitor-1 in humans. J Clin Endocrinol Metab (2002) 1.60
Pilot study of a physician-delivered education tool to increase patient knowledge about CKD. Am J Kidney Dis (2013) 1.59
Variation in the 4q25 chromosomal locus predicts atrial fibrillation after coronary artery bypass graft surgery. Circ Cardiovasc Genet (2009) 1.59
Angiotensin-converting enzyme inhibition or mineralocorticoid receptor blockade do not affect prevalence of atrial fibrillation in patients undergoing cardiac surgery. Crit Care Med (2012) 1.58
Human interventions to characterize novel relationships between the renin-angiotensin-aldosterone system and parathyroid hormone. Hypertension (2013) 1.55
Angiotensin-converting enzyme inhibition alters the inflammatory and fibrinolytic response to cardiopulmonary bypass in children. Pediatr Crit Care Med (2011) 1.52
Use of aspirin associates with longer primary patency of hemodialysis grafts. J Am Soc Nephrol (2011) 1.49
Synergistic heterozygosity for TGFbeta1 SNPs and BMPR2 mutations modulates the age at diagnosis and penetrance of familial pulmonary arterial hypertension. Genet Med (2008) 1.49
Prevalence of acidosis and inflammation and their association with low serum albumin in chronic kidney disease. Kidney Int (2004) 1.48
Use of multiple imputation method to improve estimation of missing baseline serum creatinine in acute kidney injury research. Clin J Am Soc Nephrol (2012) 1.48
Differing effects of mineralocorticoid receptor-dependent and -independent potassium-sparing diuretics on fibrinolytic balance. Hypertension (2005) 1.47
Phosphatidylinositol 3-kinase signaling determines kidney size. J Clin Invest (2015) 1.46
Pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 attenuates angiotensin II/salt-induced aortic remodeling. Arterioscler Thromb Vasc Biol (2004) 1.44
Proteomic patterns and prediction of glomerulosclerosis and its mechanisms. J Am Soc Nephrol (2005) 1.44
Oxidative stress and inflammation are associated with adiposity in moderate to severe CKD. J Am Soc Nephrol (2008) 1.44
Postoperative acute kidney injury is associated with hemoglobinemia and an enhanced oxidative stress response. Free Radic Biol Med (2011) 1.42
Centralized oversight of physician-scientist faculty development at Vanderbilt: early outcomes. Acad Med (2008) 1.42
Diets and enteral supplements for improving outcomes in chronic kidney disease. Nat Rev Nephrol (2011) 1.42
Renal epithelium regulates erythropoiesis via HIF-dependent suppression of erythropoietin. J Clin Invest (2016) 1.42
Single-base resolution maps of cultivated and wild rice methylomes and regulatory roles of DNA methylation in plant gene expression. BMC Genomics (2012) 1.40
SOAP3-dp: fast, accurate and sensitive GPU-based short read aligner. PLoS One (2013) 1.39